Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors

Lignende værker

• Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
  af: Vasudev, Naveen S., et al.
  Udgivet: (2011)
• Advances in treatment of chronic myelogenous leukemia – new treatment options with tyrosine kinase inhibitors
  af: SANTOS, FABIO P. S., et al.
  Udgivet: (2009)
• Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
  af: Roviello, Giandomenico, et al.
  Udgivet: (2021)
• Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma
  af: Ishihara, Hiroki, et al.
  Udgivet: (2017)
• Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial
  af: Oyama, Masafumi, et al.
  Udgivet: (2017)